Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TPST Tempest Therapeutics Inc.

休市中 07-24 16:00:00 EDT

0.9259

-0.0147

-1.56%

盘后0.9190

-0.0069-0.75%

19:58 EDT

最高0.9856	最低0.8695	成交量26.29万
今开0.9325	昨收0.9406	日振幅12.34%
总市值1,480万	流通市值901.05万	总股本1,598万
成交额24.52万	换手率2.70%	流通股本973.16万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TPST","market":"US","secType":"STK","nameCN":"Tempest Therapeutics Inc.","latestPrice":0.9259,"timestamp":1784923200000,"preClose":0.9406,"halted":0,"volume":262942,"hourTrading":{"tag":"盘后","latestPrice":0.919,"preClose":0.9259,"latestTime":"19:58 EDT","volume":12054,"amount":11077.1544,"timestamp":1784937537055,"change":-0.0069,"changeRate":-0.007452,"amplitude":0.045469},"delay":0,"changeRate":-0.015628322347437856,"floatShares":9731600,"shares":15979411,"eps":-5.7,"marketStatus":"休市中","change":-0.0147,"latestTime":"07-24 16:00:00 EDT","open":0.9325,"high":0.9856,"low":0.8695,"amount":245165.69039551998,"amplitude":0.123432,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.7,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.9406,"preHourTrading":{"tag":"盘前","latestPrice":0.935,"preClose":0.9406,"latestTime":"09:29 EDT","volume":21599,"amount":20086.0418876,"timestamp":1784899799084,"change":-0.0056,"changeRate":-0.005954,"amplitude":0.0404},"postHourTrading":{"tag":"盘后","latestPrice":0.919,"preClose":0.9259,"latestTime":"19:58 EDT","volume":12054,"amount":11077.1544,"timestamp":1784937537055,"change":-0.0069,"changeRate":-0.007452,"amplitude":0.045469},"volumeRatio":0.9689449147017029,"impliedVol":1.4125,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TPST","defaultTab":"news","newsList":[{"id":"1144069314","title":"Tempest宣布与森朗生物就靶向CD7的下一代体内CAR-T疗法TPST-4003达成开发合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1144069314","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144069314?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:01","pubTimestamp":1784631681,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics公司宣布，已与森朗生物就TPST-4003的开发达成合作。TPST-4003是一款靶向CD7的下一代体内嵌合抗原受体T细胞（CAR-T）疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149312324","title":"Tempest Therapeutics股东拟出售至多243万股普通股 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1149312324","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149312324?lang=zh_cn&edition=full","pubTime":"2026-06-27 04:04","pubTimestamp":1782504256,"startTime":"0","endTime":"0","summary":"据美国证券交易委员会（SEC）最新文件披露，Tempest Therapeutics Inc. 的部分现有股东计划出售其持有的公司普通股，出售股份数量最高可达243万股。此次股份出售计划由售股股东自主发起，公司本身并未发行新股或从此次出售中获得任何收益。文件显示，相关股份将根据市场情况，通过或不时在公开市场以市价交易、与市价相关的定价交易、协商交易或其他法律允许的方式进行处置。此举通常反映了股东基于自身财务规划或投资策略的考量，公司运营与资金状况不受直接影响。投资者需关注后续实际出售的规模、时机及对二级市场流动性的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117418065","title":"Tempest风险解决方案任命David Näslund为新任首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1117418065","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117418065?lang=zh_cn&edition=full","pubTime":"2026-05-20 20:30","pubTimestamp":1779280258,"startTime":"0","endTime":"0","summary":"Tempest Security AB宣布，David Näslund已被任命为Tempest风险解决方案的新任首席执行官。\nDavid Näslund将自其当前担任Verifiera首席执行官的职位加入该公司，并将于2026年6月1日正式履新。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124438881","title":"Tempest Therapeutics Inc. 将不会从售股股东出售股份中获取收益——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1124438881","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124438881?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:15","pubTimestamp":1775124913,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会（SEC）的文件显示，Tempest Therapeutics Inc. 将不会从售股股东出售公司股份的交易中获得任何收益。\n该文件明确指出，此次股份出售所涉及的资金将完全归售股股东所有，公司自身不会从中取得任何财务进账。这一安排意味着，Tempest Therapeutics 的财务状况不会因此次股权变动而受到直接影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182711550","title":"Tempest Therapeutics提交招股说明书 拟转售约280万股含认股权证股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1182711550","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182711550?lang=zh_cn&edition=full","pubTime":"2026-04-02 18:14","pubTimestamp":1775124855,"startTime":"0","endTime":"0","summary":"生物制药企业Tempest Therapeutics Inc（简称TPST）近日向美国证券交易委员会提交招股说明书，计划通过转售方式发行最多约280万股普通股，其中包含相关认股权证。该文件显示，此次转售涉及公司已发行但尚未在公开市场交易的股份，旨在为现有股东提供流动性。作为一家专注于肿瘤治疗创新的临床阶段公司，Tempest Therapeutics此次股份转售计划引发市场关注。业内人士分析，此类融资活动通常与企业研发进展及资金需求密切相关。根据SEC披露要求，该招股说明书详细载明了股份数量、转售条件及认股权证行使条款等关键信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135423386","title":"Tempest Therapeutics Inc. 股东拟转售最多827万股普通股 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1135423386","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135423386?lang=zh_cn&edition=full","pubTime":"2026-03-31 06:00","pubTimestamp":1774908013,"startTime":"0","endTime":"0","summary":"根据美国证监会最新文件披露，生物制药公司Tempest Therapeutics Inc. 现有股东计划转售公司普通股，规模上限达827万股。此次股票转售计划由售股股东主动发起，旨在通过公开市场实现部分投资退出。公司本身不参与此次股份发售，因此不会从股票转售中获得任何直接融资收益。该文件显示，相关股东已注册这批股票的非公开发行转售资格，具体交易将根据市场情况择机进行。作为临床阶段肿瘤治疗领域的创新企业，Tempest Therapeutics 目前正推进多项抗癌疗法研发项目，此次股权变动可能引发市场对其资本结构的关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180728911","title":"Tempest Therapeutics公布TPST-2003在Redeem-1期1/2a试验中的积极中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1180728911","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180728911?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:02","pubTimestamp":1774875752,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics公司近日披露了其核心候选药物TPST-2003在Redeem-1期1/2a临床试验中取得的中期分析结果，数据显示出令人鼓舞的疗效信号。该阶段性成果不仅验证了药物的作用机制，更为后续临床开发提供了关键依据。研究人员指出，这些积极数据将加速推进TPST-2003在肿瘤治疗领域的应用探索。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124401307","title":"Tempest宣布Tpst-2003合作计划，为2026年美国注册研究铺路","url":"https://stock-news.laohu8.com/highlight/detail?id=1124401307","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124401307?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:03","pubTimestamp":1773230591,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. (简称Tempest) 近日披露了一项关于其核心候选药物Tpst-2003的战略合作。这一重要举措旨在为2026年在美国启动的注册性研究做好充分准备。合作将整合多方资源，加速该药物的临床开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171963738","title":"Tempest Therapeutics：公司同时探索将TPST-2003的潜在开发范围扩展至LBCL患者及其他相关适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1171963738","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171963738?lang=zh_cn&edition=full","pubTime":"2026-02-25 21:02","pubTimestamp":1772024532,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc. 正在积极拓展其研发管线，公司目前正探索将核心候选药物TPST-2003的潜在开发计划延伸至淋巴瘤B细胞淋巴瘤（LBCL）患者群体，并覆盖其他相关适应症。这一战略动向显示出公司致力于挖掘该疗法在更广泛疾病领域中的应用潜力，旨在为更多患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517923710","title":"Tempest Therapeutics, Inc.盘中异动 下午盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517923710?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:27","pubTimestamp":1741202872,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时27分，Tempest Therapeutics, Inc.股票出现异动，股价大幅上涨5.22%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.05%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032752abea042e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032752abea042e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514033299","title":"Tempest Therapeutics, Inc.盘中异动 快速下挫5.65%报0.781美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514033299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514033299?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:22","pubTimestamp":1740687755,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时22分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.65%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1923.81%、370.28%、193.42%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280422369895504d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280422369895504d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513217948","title":"Tempest Therapeutics, Inc.盘中异动 急速下跌5.06%报0.861美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513217948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513217948?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:59","pubTimestamp":1740171553,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时59分，Tempest Therapeutics, Inc.股票出现波动，股价急速下跌5.06%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222045913abd7fddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222045913abd7fddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511578140","title":"Tempest Therapeutics, Inc.盘中异动 大幅上涨5.10%报0.944美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511578140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511578140?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:20","pubTimestamp":1739467238,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日01时20分，Tempest Therapeutics, Inc.股票出现异动，股价快速上涨5.10%。截至发稿，该股报0.944美元/股，成交量74.1309万股，换手率1.70%，振幅4.76%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214012039a244ce2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214012039a244ce2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510865671","title":"Tempest Therapeutics, Inc.盘中异动 早盘大幅拉升6.12%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510865671?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197882,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Tempest Therapeutics, Inc.股票出现波动，股价快速上涨6.12%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223122a240a1be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223122a240a1be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508141356","title":"Tempest Therapeutics, Inc.盘中异动 早盘快速下挫5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141356?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593151,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.85%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322323298796f1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322323298796f1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506574582","title":"Tempest Therapeutics, Inc.盘中异动 临近收盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506574582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506574582?lang=zh_cn&edition=full","pubTime":"2025-01-28 04:36","pubTimestamp":1738010218,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日04时36分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.03%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804365896126de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804365896126de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503964206","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503964206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503964206?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951590,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分，Tempest Therapeutics, Inc.股票出现异动，股价急速下挫5.32%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Allovir, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.52%、56.84%、35.49%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522331098673ba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522331098673ba1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503884275","title":"Tempest Therapeutics, Inc.盘中异动 早盘大幅下挫5.02%报0.902美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503884275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503884275?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778730,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.02%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2741.64%、1797.61%、390.72%，振幅较大的相关个股有Exicure, Inc.、Verrica制药、Champions Oncology, Inc.，振幅分别为110.04%、106.80%、101.18%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223210a2203f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223210a2203f05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494945384","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大跌5.26%报0.837美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494945384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494945384?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:22","pubTimestamp":1735312923,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时22分，Tempest Therapeutics, Inc.股票出现波动，股价快速跳水5.26%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232203a20c0948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232203a20c0948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493576415","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493576415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493576415?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:40","pubTimestamp":1734964825,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时40分，Tempest Therapeutics, Inc.股票出现异动，股价快速拉升5.13%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322402895eadbcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322402895eadbcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tempesttx.com","stockEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.2018},{"period":"3month","weight":-0.4827},{"period":"6month","weight":-0.6893},{"period":"1year","weight":-0.8561},{"period":"ytd","weight":-0.6774}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tempest Therapeutics Inc成立于2011年4月5日。该公司是一家临床阶段的生物技术公司，致力于推进针对癌症和免疫学适应症的多元化细胞疗法和小分子候选药物组合。其研发管线包括用于多发性骨髓瘤的CD19/BCMA双靶点CAR-T疗法，以及用于肝细胞癌和家族性腺瘤性息肉病的小分子候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.012727},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.032927},{"month":3,"riseRate":0.461538,"avgChangeRate":0.000618},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.113004},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.011916},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.124765},{"month":7,"riseRate":0.214286,"avgChangeRate":-0.035291},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.054209},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.059229},{"month":10,"riseRate":0.461538,"avgChangeRate":0.94597},{"month":11,"riseRate":0.384615,"avgChangeRate":-0.081423},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.062561}],"exchange":"NASDAQ","name":"Tempest Therapeutics Inc.","nameEN":"Tempest Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tempest Therapeutics Inc.(TPST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tempest Therapeutics Inc.,TPST,Tempest Therapeutics Inc.股票,Tempest Therapeutics Inc.股票老虎,Tempest Therapeutics Inc.股票老虎国际,Tempest Therapeutics Inc.行情,Tempest Therapeutics Inc.股票行情,Tempest Therapeutics Inc.股价,Tempest Therapeutics Inc.股市,Tempest Therapeutics Inc.股票价格,Tempest Therapeutics Inc.股票交易,Tempest Therapeutics Inc.股票购买,Tempest Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tempest Therapeutics Inc.(TPST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}